|
EP1787660A1
|
|
New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
|
|
EP1782826A1
|
|
PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions
|
|
EP1776963A1
|
|
Hexosylceramides as adjuvants and their uses in pharmaceutical compositions
|
|
EP1743897A1
|
|
Biologically active compounds obtainable from Sorangium cellulosum
|
|
EP1619241A1
|
|
Genetic modification system for myxobacteria
|
|
EP1655370A1
|
|
Bacterial vector
|
|
EP1652932A1
|
|
Method for the generation of virus producing cell lines and cell lines
|
|
DE102004046024A1
|
|
Antibiotic and method of preparation
|
|
DE102004042102A1
|
|
Process for regio-selective oxidation
|
|
EP1614747A1
|
|
New esterases from rumen
|
|
EP1612267A1
|
|
Cellulases from rumen
|
|
EP1607482A1
|
|
RNAi-based methods for selection of transfected eucaryotic cells
|
|
DE102004023906A1
|
|
Process for the preparation of chemical microarrays
|
|
WO2004099362A2
|
|
Method, apparatus and system for separating eucaryotic or procaryotic cells or other particularly biological material from a suspension
|
|
WO2004087862A2
|
|
Tak1-mediated inhibition of osteogenesis
|
|
DE10340429A1
|
|
Hydrophobic object with a pattern of hydrophilic areas, its production and use
|
|
EP1484064A1
|
|
Therapeutical composition containing dentritic cells and use thereof
|
|
EP1475433A1
|
|
Transfection method for mammalian cells
|
|
CA2423897A1
|
|
Methods for treating lung infections and lung tumors and for treating and preventing lung metastases
|
|
EP1520025A2
|
|
Nucleic acid molecules involved in the synthesis of melithiazols
|
